This page is general health information. It is not advice about your own treatment and it does not promote any medicine. Whether a medicine is right for you is a decision for you and your prescriber.

The medicines used for ADHD in New Zealand

Medicine Type Brands funded in NZ How long a dose lasts
Methylphenidate, immediate release Stimulant Ritalin, Rubifen About 3 to 5 hours
Methylphenidate, sustained release Stimulant Rubifen SR Up to 8 hours
Methylphenidate, long acting Stimulant Ritalin LA, Rubifen LA About 6 to 8 hours
Methylphenidate, extended release Stimulant Concerta, Methylphenidate ER (Teva), Methylphenidate Sandoz XR Up to 12 hours
Dexamfetamine Stimulant Dexamfetamine (Noumed, Aspen) 4 to 6 hours
Lisdexamfetamine Stimulant Vyvanse 8 to 14 hours
Atomoxetine Non-stimulant Atomoxetine Taken every day

Durations are from bpac's 2026 guidance for New Zealand primary care. People vary, and your prescriber will choose a medicine and form based on your health, your day and what is available.

Stimulants

bpac describes stimulants as the first-line medicines for adults with ADHD. In New Zealand methylphenidate is often tried first because clinicians are most familiar with it. Lisdexamfetamine and dexamfetamine are the alternatives.

Healthify notes that medicines are optional and are used alongside changes to routines and habits, not instead of them.

Non-stimulants

Atomoxetine is the non-stimulant option. bpac says it is usually kept for people who cannot take stimulants, who have not responded well to them, or where there is a concern about a stimulant being misused. More in non-stimulant ADHD medication.

Funding

  • Stimulants are funded by Pharmac under a Special Authority. Your prescriber applies for it. The requirement to renew the approval every two years was removed on 1 December 2024, so an approval now stays valid.
  • Atomoxetine is funded without restriction.
  • From 1 February 2026, GPs and nurse practitioners who start treatment for adults can make the Special Authority application themselves.

With a funded medicine you pay the standard prescription charge at the pharmacy.

Prescription rules

Methylphenidate, dexamfetamine and lisdexamfetamine are Class B controlled drugs, so the rules are tighter than for most medicines.

  • On an electronic prescription, a prescriber can write up to three months' supply at once.
  • The pharmacy still dispenses one month at a time.
  • You pay one prescription charge for the three months.
  • A paper prescription is limited to one month.

Checks before starting

bpac advises prescribers to do the following before starting a stimulant:

  • Review your medical history and the medicines you already take.
  • Record your weight, heart rate and blood pressure.
  • Ask about alcohol and drug use.
  • Agree on the symptoms being targeted and how you will both judge whether the medicine helps.

An ECG or a heart specialist's opinion may be appropriate for some people. bpac lists high blood pressure, known heart conditions, a close relative who died suddenly of a heart problem before 40, and symptoms such as fainting, palpitations or chest pain on exertion.

Follow-up

  • An in-person review within two to four weeks of starting.
  • The dose is usually settled within about eight weeks.
  • Reviews every six months once things are stable, including whether the medicine is still needed.

Supply

Methylphenidate supply has been constrained in recent years. Because it is a controlled drug, international rules limit how much can be imported, so supply cannot be increased quickly. The 2026 rule change was delayed from July 2025 over supply concerns, and Pharmac began funding an additional brand, Methylphenidate Sandoz XR, from 1 December 2025.

If your usual brand is out of stock, talk to your pharmacist and prescriber. Do not stop or swap a medicine on your own.

Where to read more

  • Healthify's pages on each medicine, written for patients.
  • The Consumer Medicine Information leaflet for your medicine, available from your pharmacist or on the Medsafe website.
  • Side effects of ADHD medication.

Common questions

What ADHD medication is available in New Zealand?

The stimulant medicines are methylphenidate, dexamfetamine and lisdexamfetamine. The non-stimulant is atomoxetine. All four are funded by Pharmac, with a Special Authority approval needed for the stimulants.

Who can prescribe ADHD medication in NZ?

Psychiatrists and paediatricians, and since 1 February 2026, vocationally registered GPs and nurse practitioners for adults aged 18 and over, within their area of practice. Other GPs can continue prescriptions that one of these clinicians has started.

How much does ADHD medication cost in NZ?

Funded medicines cost the standard prescription charge at the pharmacy. With an electronic prescription, stimulants can be prescribed for three months at a time and you pay one charge for the three months. Your prescriber may charge for appointments and repeats.

Do I have to take medication if I am diagnosed with ADHD?

No. Healthify describes medicines as optional, used alongside lifestyle and behaviour changes. A diagnosis is useful on its own, and other support such as therapy and practical strategies does not depend on taking medicine.

Is there a shortage of ADHD medication in New Zealand?

Supply of methylphenidate has been tight. It is a controlled drug with international limits on how much can be imported. Pharmac began funding an additional brand from 1 December 2025 to improve supply. Your pharmacist will know what is in stock.

Sources

This page is general information, not medical advice. How we write and check pages